Market Cap 77.92M
Revenue (ttm) 9.78M
Net Income (ttm) -7.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -73.82%
Debt to Equity Ratio 0.00
Volume 877,886
Avg Vol 2,504,516
Day's Range N/A - N/A
Shares Out 129.61M
Stochastic %K 32%
Beta 0.14
Analysts Strong Buy
Price Target $0.85

Company Profile

NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharma...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 899 8800
Website: novabay.com
Address:
2000 Powell Street, Suite 1150, Emeryville, United States
Latest News on NBY
No data available.